Baltimore, MDNCT07222670Now EnrollingIRB Ready

Viral Respiratory Infection Clinical Trial in Baltimore, MD

Access cutting-edge viral respiratory infection treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by ENA Respiratory Pty Ltd

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access viral respiratory infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related viral respiratory infection treatment provided free

Apply for This Baltimore Location

Check if you qualify for this viral respiratory infection clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Viral Respiratory Infection Study in Baltimore

Acute upper and lower respiratory infections are a major public health problem and a leading cause of morbidity and mortality worldwide. The purpose of this trial is to assess the safety of the investigational agent INNA-051, given intranasally, and its potential effectiveness in reducing the occurrence, severity, and/or the duration of illness resulting from respiratory virus infections. The trial will enroll generally healthy adults (age 18 - 45 years) who are at risk for exposure to viral respiratory infection, for example, due to living conditions or occupation. Participants will be treated with INNA-051 or placebo once weekly for 4 weeks (Part A) or 12 weeks (Part B) during the respiratory virus season.

Sponsor: ENA Respiratory Pty Ltd

Who Can Participate

Inclusion Criteria

In good general health and without clinically significant medical, psychiatric, chronic or intermittent health conditions.
At risk for exposure to viral respiratory infection, for example, living in crowded housing, university housing, or military barracks, working in a childcare center or caring for a child aged 10 or less, healthcare workers, factory workers, taxi and bus drivers, grocery clerks, and educators or counselors who work in crowded environments or with multiple exposures with different people daily.
Agree to use highly effective birth control.

Exclusion Criteria

Presence of Type I or Type II diabetes, asthma or other chronic respiratory condition.
Active infections including Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency (HIV).
Concurrent participation in another clinical trial involving investigational product or prior receipt of investigational product within 90 days or 5 half-lives of the product.
Active clinical signs or symptoms of acute respiratory illness (runny nose, sore throat, fever, etc.).
Received a vaccine against Respiratory Syncytial Virus (RSV) or COVID-19 within 180 days.
Pregnant or lactating women.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT07222670) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Viral Respiratory Infection Treatment Options in Baltimore, MD

If you're searching for viral respiratory infection treatment options in Baltimore, MD, this clinical trial (NCT07222670) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced viral respiratory infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all viral respiratory infection clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Baltimore, MD

See all rheumatoid arthritis clinical trials recruiting in Baltimore — not just this study.

Browse Rheumatoid Arthritis Trials in Baltimore →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsPneumonia TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD